semaglutide cardiovascular outcomes news 2025 Comparative of to dulaglutide in patients with type 2 diabetes ADA 2025: Oral Semaglutide Demonstrates

However, its use in this specific patient population demands a personalized approach, careful monitoring, and ongoing research to fully understand its long-term effects

The majority of studies measured total, free and acylcarnitine levels, except for Ascha et al

For this study, we were interested in understanding on- and off-label drug prescribing patterns of newer GLP-1-based drugs approved for either T2DM or weight loss

When will you see results with Cagrilintide

Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats

The primary outcome was a composite of major adverse cardiovascular events (MACE), defined as cardiovascular death, myocardial infarction, or ischemic stroke